OBJECTIVE: To examine impact on perinatal outcome of untreated gestational diabetes (GDM) and non-diabetics stratified by body mass index (BMI). RESEARCH DESIGN AND METHODS: This is a secondary analysis of our investigation of the consequences of not treating GDM. We evaluated 555 untreated GDMs matched to 1100 non-diabetics. BMI was determined using subjects' recalled pre-pregnancy weight. A primary composite variable consisted of stillbirth, neonatal macrosomia/large-for-gestational-age (LGA), neonatal hypoglycemia, erythrocytosis and hyperbilirubinemia. Secondary outcomes included shoulder dystocia, respiratory complications, cesarean delivery and pregnancy-related hypertension. RESULTS: Untreated subjects in the normal weight category had an ∼2-fold increase for composite outcome and LGA and a 7-fold increase in metabolic complications. The overweight untreated group showed composite outcome, LGA and metabolic complications 2-3-fold higher and induction of labor 5-fold higher. For obese untreated GDMs, significantly higher rates of composite outcome, LGA and metabolic complications, induction of labor and cesarean delivery were 10-, 3-, 5-, 4- and 9-fold, respectively. Perinatal outcome for normal weight untreated GDM was similar to obese non-diabetics. CONCLUSIONS: Maternal obesity and GDM independently affect adverse pregnancy outcome. The combination has a greater impact than each one alone. However, glycemic level contributes a greater portion to the adverse pregnancy equation.
OBJECTIVE: To examine impact on perinatal outcome of untreated gestational diabetes (GDM) and non-diabetics stratified by body mass index (BMI). RESEARCH DESIGN AND METHODS: This is a secondary analysis of our investigation of the consequences of not treating GDM. We evaluated 555 untreated GDMs matched to 1100 non-diabetics. BMI was determined using subjects' recalled pre-pregnancy weight. A primary composite variable consisted of stillbirth, neonatal macrosomia/large-for-gestational-age (LGA), neonatal hypoglycemia, erythrocytosis and hyperbilirubinemia. Secondary outcomes included shoulder dystocia, respiratory complications, cesarean delivery and pregnancy-related hypertension. RESULTS: Untreated subjects in the normal weight category had an ∼2-fold increase for composite outcome and LGA and a 7-fold increase in metabolic complications. The overweight untreated group showed composite outcome, LGA and metabolic complications 2-3-fold higher and induction of labor 5-fold higher. For obese untreated GDMs, significantly higher rates of composite outcome, LGA and metabolic complications, induction of labor and cesarean delivery were 10-, 3-, 5-, 4- and 9-fold, respectively. Perinatal outcome for normal weight untreated GDM was similar to obese non-diabetics. CONCLUSIONS:Maternal obesity and GDM independently affect adverse pregnancy outcome. The combination has a greater impact than each one alone. However, glycemic level contributes a greater portion to the adverse pregnancy equation.
Authors: Kennedy S Mdaki; Tricia D Larsen; Angela L Wachal; Michelle D Schimelpfenig; Lucinda J Weaver; Samuel D R Dooyema; Eli J Louwagie; Michelle L Baack Journal: Am J Physiol Heart Circ Physiol Date: 2016-01-22 Impact factor: 4.733
Authors: Michelle L Baack; Benjamin J Forred; Tricia D Larsen; Danielle N Jensen; Angela L Wachal; Muhammad Ali Khan; Peter F Vitiello Journal: PLoS One Date: 2016-08-12 Impact factor: 3.240
Authors: Verónica Melero; Carla Assaf-Balut; Nuria García de la Torre; Inés Jiménez; Elena Bordiú; Laura Del Valle; Johanna Valerio; Cristina Familiar; Alejandra Durán; Isabelle Runkle; María Paz de Miguel; Carmen Montañez; Ana Barabash; Martín Cuesta; Miguel A Herraiz; Nuria Izquierdo; Miguel A Rubio; Alfonso L Calle-Pascual Journal: J Clin Med Date: 2020-05-13 Impact factor: 4.241